ARTICLE | Clinical News
Bystolic nebivolol regulatory update
December 7, 2009 8:00 AM UTC
FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Jan. 11 to discuss an sNDA from Forest for Bystolic nebivolol to treat congestive heart failure (CHF). The adrenergic receptor bet...